One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Fresh official labeling adds the renal cap together with the cardiovascular and treatment-selection restrictions; the earlier RX source remains separately dated.
What to reconcile: Check the allopurinol treatment history, cardiovascular risk, renal range and interacting medicines before applying the renal limit.
Open this note and its source referencesCheck the allopurinol treatment history, cardiovascular risk, renal range and interacting medicines before applying the renal limit.
The cardiovascular-death boxed warning remains relevant; no-adjustment wording is not cardiovascular clearance.
Concomitant azathioprine or mercaptopurine is contraindicated. Do not apply this gout regimen to asymptomatic or secondary hyperuricemia.
| CrCl (mL/min) | Source-specific instruction |
|---|---|
| 30-89 | No renal dose adjustment |
| 15-29 | Limit to 40 mg once daily |
| ESRD on dialysis | Not studied; no regimen established by the selected source |
ULORIC renal dose limit
| CrCl (mL/min) | Source-specific instruction |
|---|---|
| 30-89 | No renal dose adjustment |
| 15-29 | Limit to 40 mg once daily |
| ESRD on dialysis | Not studied; no regimen established by the selected source |
The cardiovascular-death boxed warning remains relevant; no-adjustment wording is not cardiovascular clearance.
Concomitant azathioprine or mercaptopurine is contraindicated. Do not apply this gout regimen to asymptomatic or secondary hyperuricemia.
RDM64-official-febuxostat-uloric-67fd73deaf-C1 · Source locator: Boxed warning; sections 1, 2.2, 4, 8.6 and 12.3.
The cardiovascular-death boxed warning remains relevant; no-adjustment wording is not cardiovascular clearance.
Concomitant azathioprine or mercaptopurine is contraindicated. Do not apply this gout regimen to asymptomatic or secondary hyperuricemia.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=febuxostat-uloric&s1=RDM64-official-febuxostat-uloric-67fd73deaf&h1=39d7f33a7e781d38f574a5918e31485eb0ed2d473313dfdba71afff132f0420e